课题基金 / 基金详情

I: Penn State Institutional Career Development Core

I: Penn State Institutional Career Development Core
I:宾夕法尼亚州立大学机构职业发展核心
批准号:
10670912
负责人:
Lauren Jodi Van Scoy
金额:
$59.82万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-09-15 至 2026-06-30

项目摘要

项目成果

Lauren Jodi Van Scoy的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要-宾夕法尼亚州立大学机构职业发展核心 临床和翻译科学(CTS)研究的效率、质量和影响方面的进展将是 由经过严格研究方法培训并具备驾驭 从基本发现到改善健康的途径。宾夕法尼亚州立大学临床与翻译学院的总体目标 理工学院(CTSI)机构职业发展计划将加速学者过渡到 研究独立性。我们的优先事项包括增加我们学者的种族、民族和科学多样性, 利用创新战略吸引和指导学者提高研究生产力,推广 参与农村卫生研究,完善我们以数据为驱动的持续方案改进。我们 将招募具有突出潜力的KL2学者,成为生物医学研究创新的催化剂 翻译。在此申请中,我们请求支持4名KL2学者,并有机构承诺 额外的4名学者。所有受助学金资助和机构资助的学者将通过 大学范围内的RFA,有机会获得相同的职业发展机会,并对 在发展科学独立性方面的进展。被选中的学者将在一次密集的 为期3年的计划,旨在培养CTS的下一代领导者。我们的目标是: 1.招募和聘用来自不同背景的有才华的学者合作临床和 翻译科学(CTS)职业发展。 2.对现有和新近的学者实施密集的指导/指导战略,以将 关于学者向独立过渡的曲线。 3.利用我们CTSL农村环境、合作伙伴关系和技术的优势,开发 CTS农村卫生研究实践。 4.完善在逻辑模型指导下收集、分析和利用评价数据的流程 促进职业发展计划的持续质量改进。 我们认识到学者们向独立过渡的多种因素,包括他们的主动性, 坚持不懈、韧性、支持性指导、与合作者的互动、受保护的研究时间,以及 机构研究基础设施和文化。独立道路上里程碑的时机也是如此 根据每个人之前的培训情况而有所不同。我们的方案产品与 翻译努力核心、社区参与研究核心(CERC)和TL 1计划,以及 包括高级学位、核心研讨会、体验机会、个人课程、学习模块以及 个性化学习的灵活性。预期结果是有能力的翻译研究人员,具有以下技能 通过弥合翻译研究连续体中的差距和创新来加速发现。
英文摘要
PROJECT SUMMARY/ABSTRACT-PENN STATE INSTITUTIONAL CAREER DEVELOPMENT CORE Advances in the efficiency, quality and impact of clinical and translational science (CTS) research will be achieved by researchers who are trained in rigorous research methodologies and equipped to navigate a pathway from basic discovery to improved health. The overall goal of the Penn State Clinical and Translational Science lnstitute's (CTSI) Institutional Career Development Program is to accelerate scholar transition to research independence. Our priorities include increasing the racial, ethnic, and scientific diversity of our scholars, utilizing innovative strategies to engage and guide scholars to enhance research productivity, extending engagement in rural health research, and refining our data-driven continuous programmatic improvement. We will recruit KL2 scholars with outstanding potential to become catalysts for innovation in biomedical research translation. In this application we request support for 4 KL2 scholars and have an institutional commitment for an additional 4 scholars. All grant-funded and institutionally funded scholars will be selected through a University-wide RFA, have access to the same career development opportunities, and same expectations for progress toward development of scientific independence. The selected scholars will be enrolled in an intensive 3-year program designed to prepare the next generation of leaders in CTS. Our Aims are to: 1. Recruit and engage talented scholars from diverse backgrounds in collaborative clinical and translational sciences (CTS) career development. 2. Implement an intensive mentoring/coaching strategy for current and recent scholars to "turn the curve" on scholar transition to independence. 3. Leverage the strengths of our CTSl's rural environment, partnerships and technologies to develop a CTS research practicum in rural health. 4. Refine processes for collection, analysis and utilization of evaluative data guided by the logic model to foster continuous quality improvement of the career development program. We recognize multiple factors contribute to the scholars' transition to independence, including their initiative, persistence, resilience, supportive mentorship, interactions with collaborators, protected research time, and the institutional research infrastructure and culture. Timing for milestones on the path toward independence also varies depending on each individual's prior training. Our programmatic offerings are coordinated with the Translational Endeavors Core, the Community Engaged Research Core (CERC) and the TL 1 program, and include advanced degrees, core seminars, experiential opportunities, individual courses, learning modules, and flexibility for individualized learning. Intended outcomes are competent translational researchers with skills to accelerate discovery by bridging gaps and innovation along the translational research continuum.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1210/jcemcr/luad103
发表时间: 2023-09
期刊: JCEM case reports
影响因子: --
作者: []
通讯作者:
DOI: 10.1177/17455057231219601
发表时间: 2023-01
期刊: WOMENS HEALTH
影响因子: 2.4
作者: [Horvath, Sarah, Frietsche, Susan]
通讯作者: Frietsche, Susan
Chronic Generalized Lymphadenopathy in a Child-Progressive Transformation of Germinal Centers (PTGC).
生发中心儿童促进转化(PTGC)的慢性广义淋巴结肿大。
DOI: 10.3390/children9020214
发表时间: 2022-02-06
期刊: Children (Basel, Switzerland)
影响因子: --
作者: [Wills C, Mercer K, Malysz J, Rivera Galvis L, Gowda C]
通讯作者: Gowda C
DOI: 10.1097/inf.0000000000002663
发表时间: 2020-08
期刊: The Pediatric infectious disease journal
影响因子: --
作者: [Ericson JE, Hornik CP, Greenberg RG, Clark RH, Tremoulet AH, Le J, Cohen-Wolkowiez M, Smith PB, Benjamin DK Jr, Best Pharmaceuticals for Children Act – Pediatric Trials Network]
通讯作者: Best Pharmaceuticals for Children Act – Pediatric Trials Network
共 6 条
    Engaging underserved communities in end-of-life conversations: a cluster, randomized controlled trial
    Engaging underserved communities in end-of-life conversations: a cluster, randomized controlled trial
    海外基金